Clinical Trials Browser

Phase EARLY_PHASE1 × Recruiting × INDUSTRY × Clear all

NCT07274813 2026-03-03

A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX37 in Advanced/Metastatic Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasmThoracic

Advanced/Metastatic Solid Tumors

NCT06305962 2026-02-19

177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors

Phase EARLY_PHASE1 Recruiting

BreastDermatologicGynecologicHead & NeckThoracic

Turcot syndrome, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Melanoma, Endometrial Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

NCT06824155 2026-02-11

RAD202

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

HER2 Gene Mutation

NCT07378436 2026-01-30

A Clinical Study of GK02 in Malignant Ascites

Phase EARLY_PHASE1 Recruiting

Gastrointestinal

Stomach Neoplasms

NCT06653023 2026-01-20

Wondercel-UWD3

Phase EARLY_PHASE1 Recruiting

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Hepatocellular

NCT06662227 2026-01-20

Universal CAR-T Cells (REVO-UWD-19) for Refractory and Relapsed B-Cell Tumors

Phase EARLY_PHASE1 Recruiting

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Lymphoma, B-Cell

NCT06663046 2026-01-20

Universal CAR-T Cells (REVO-UWD-00B) for Refractory and Relapsed Multiple Myeloma

Phase EARLY_PHASE1 Recruiting

Multiple Myeloma

NCT06653010 2026-01-16

Wondercel-UWD1

Phase EARLY_PHASE1 Recruiting

Gastrointestinal

Colorectal Neoplasms

NCT07336823 2026-01-13

JY232(JY232) Injection in Relapsed/Refractory Multiple Myeloma

Phase EARLY_PHASE1 Recruiting

Multiple Myeloma

NCT07131254 2025-12-30

A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in Adult Participants With Relapsed/Refractory CD19-positive B-cell Malignant Hematological Tumors

Phase EARLY_PHASE1 Recruiting

Other hematologic neoplasm

Hematologic Neoplasms

NCT06645808 2025-12-29

VARTUTRACE

Phase EARLY_PHASE1 Recruiting

BreastCNSGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Breast Neoplasms, Chondrosarcoma, Colonic Neoplasms, Esophageal Neoplasms, Glioblastoma, Lung Neoplasms, Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Sarcoma, Osteosarcoma, Stomach Neoplasms

NCT07205315 2025-12-26

A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-positive B-cell Hematologic Malignancies and Autoimmune Hemolytic Anemia

Phase EARLY_PHASE1 Recruiting

Classical hematologyLymphoidOther hematologic neoplasm

Anemia, Hemolytic, Autoimmune, Burkitt Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell

NCT04960072 2025-12-23

A Study of GC101 TIL in r/r Gastrointestinal Tumors (10hospital)

Phase EARLY_PHASE1 Recruiting

Gastrointestinal

Digestive System Neoplasms

NCT06488950 2025-12-16

A Study of TIL in Advanced Solid Tumors (DFGD)

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Advanced Solid Tumor

NCT04943913 2025-12-11

Study of GC101 TIL in Brain Glioma (Soochow2)

Phase EARLY_PHASE1 Recruiting

Glioma

NCT05098171 2025-12-11

A Study of GC201 TIL in Advanced Gynecologic Tumors (10hospital)

Phase EARLY_PHASE1 Recruiting

Advanced Gynecologic Tumors

NCT05098184 2025-12-11

A Study of GC101 TIL in Advanced Melanoma (10hospital)

Phase EARLY_PHASE1 Recruiting

Advanced Melanoma

NCT05098197 2025-12-11

A Study of GC101 TIL in Advanced Hepatobiliary-Pancreatic Cancers (10hospital)

Phase EARLY_PHASE1 Recruiting

Gastrointestinal

Advanced Liver Cancers

NCT05142475 2025-12-11

A Study of GC101 TIL in Advanced Breast Cancer (10hospital)

Phase EARLY_PHASE1 Recruiting

Breast Neoplasms

NCT07077616 2025-12-08

TAMAVAQTM

Phase EARLY_PHASE1 Recruiting

Glioma

NCT07246304 2025-11-24

TC-D101 Cell Therapy for Patients With DLL3-Positive SCLC

Phase EARLY_PHASE1 Recruiting

Small Cell Lung Carcinoma

NCT06446128 2025-08-21

A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed or Refractory B Cell Non-Hodgkin Lymphoma(NHL)

Phase EARLY_PHASE1 Recruiting

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell

NCT05245058 2025-08-17

SPH5030 Tablets in Subjects With Advanced Her2-positive Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

HER2-positive Advanced Solid Tumors

NCT06822998 2025-08-17

HF50

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT06700070 2025-08-11

A Phase 0 Multicenter Study of the Pharmacodynamic Effects of Intratumoral Microdose Administration of PBA-0111 in Patients With Solid Tumors

Phase EARLY_PHASE1 Recruiting

BreastHead & Neck

Squamous Cell Carcinoma of Head and Neck, Triple Negative Breast Neoplasms

NCT06675513 2025-05-20

Autologous CAR-T Cells (WD-01) for Metastatic Colorectal Cancer

Phase EARLY_PHASE1 Recruiting

Gastrointestinal

Colorectal Neoplasms

NCT06092047 2025-05-16

UTAA09 Injection in the Treatment of Relapsed/Refractory Hematolymphatic Malignancies.

Phase EARLY_PHASE1 Recruiting

CD19-positive Relapsed or Refractory B-cell Malignancies

NCT06400485 2025-05-02

AMT-676 in Patients With Advanced Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Advanced Solid Tumors

NCT04480645 2025-02-25

CivaDerm(TM) Surface Therapy Pilot Study

Phase EARLY_PHASE1 Recruiting

Carcinoma, Basal Cell, Skin Neoplasms

NCT06834542 2025-02-19

Clinical Study of GT201 in the Treatment of Advanced Gynecological Tumors

Phase EARLY_PHASE1 Recruiting

Adult Gynecological Tumors

NCT06094426 2025-02-17

Autologous Tumor Infiltrating Lymphocyte Injection for the Treatment of Advanced Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Solid Tumor

NCT05651178 2025-01-07

Human CD19-CD22 Targeted T Cells Injection for Refractory/Relapsed Central Nervous System Leukemia/Lymphoma Patients

Phase EARLY_PHASE1 Recruiting

Lymphoma, Recurrence

NCT06209606 2024-12-17

Pilot Study Using Changes in Serum BCMA to Determine Disease Progression in Multiple Myeloma

Phase EARLY_PHASE1 Recruiting

Multiple Myeloma

NCT06732232 2024-12-13

A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed/ Refractory Multiple Myeloma

Phase EARLY_PHASE1 Recruiting

Multiple Myeloma, Recurrence

NCT06697665 2024-11-20

An Exploratory Clinical Study to Evaluate the Safety, Tolerability, Immune Response and Preliminary Efficacy of LM103 Injection in Combination With PD-1 in Patients With Advanced Solid Tumours

Phase EARLY_PHASE1 Recruiting

Solid Cancer

NCT06695689 2024-11-19

An Investigator-initiated Clinical Study of LM303 Injection for the Treatment of Advanced Solid Tumours

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Solid Tumor

NCT06532643 2024-09-19

Safety and Efficacy of Anti-CD20/CD30 CAR-T Cells in Subjects with Relapsed/Refractory Lymphoma

Phase EARLY_PHASE1 Recruiting

Lymphoma

NCT03537482 2024-08-19

APG-2575 Study of Safety, Tolerability ,PK/PD in Patients With Hematologic Malignancies

Phase EARLY_PHASE1 Recruiting

Other hematologic neoplasm

Hematologic Neoplasms

NCT06541405 2024-08-07

Safety and Efficacy of NK520 to Treat Pediatric Relapsed/Refractory Acute Myeloid Leukemia

Phase EARLY_PHASE1 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT06541444 2024-08-07

Safety and Efficacy of NK520 to Treat Relapsed/Refractory Acute Myeloid Leukemia

Phase EARLY_PHASE1 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT05707325 2024-07-24

Reboot-101

Phase EARLY_PHASE1 Recruiting

Other hematologic neoplasm

Neoplasms, Hematologic Neoplasms

NCT04541108 2024-04-18

Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies

Phase EARLY_PHASE1 Recruiting

DermatologicHead & NeckLymphoidSarcoma

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Lymphoma, Melanoma, Sarcoma

NCT05087745 2024-04-17

A Clinical Study on TIL for the Treatment of Advanced Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Advanced Solid Tumor

NCT06327997 2024-03-25

An Exploratory Study by Fast CAR T Cells

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Solid Tumor

NCT06248697 2024-02-08

Exploratory Study of MSLN-CAR T Cells Secreting PD1/CTLA-4 Nanoantibody for the Treatment of Advanced Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Solid Tumor

NCT06249256 2024-02-08

An Exploratory Study on the Treatment of Advanced Solid Tumors by Fast CAR T Cells

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Solid Tumor

NCT03863145 2024-02-07

Study to Evaluate Maximum Tolerated Dose of Oral CB-03-10 With Dose Expansion Phase, in Advanced Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Advanced Refractory Solid Tumors

NCT06171282 2023-12-14

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Bone and Soft Tissue Tumors

Phase EARLY_PHASE1 Recruiting

Bone Neoplasms, Sarcoma, Osteosarcoma

NCT05539833 2023-04-03

KSH01-TCRT

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

TCR-T Cells

NCT05580796 2023-04-03

KSH01-R02-101 Solid Tumors

Phase EARLY_PHASE1 Recruiting

Other solid neoplasm

Solid Tumor